Insmed Inc (INSM): Changewave alliance report From...

Reply Private New

Next 10 Prev Next

ED20332

Send PM Follow Ignore

Followers	0
Posts	179
Boards Moderated	0
Alias Born	09/06/2003

ED20332

Re: None

Friday, 05/11/2007 7:07:14 PM

Friday, May 11, 2007 7:07:14 PM

Changewave alliance report

From this weeks alliance report on hot tickets...#(3) Insmed Positioning for Biologics Market

"While Insmed (INSM) recently settled with competitors Tercica and Genentech, there appears to be a new story is in the making. Insmed Therapeutic Proteins (ITP) - their manufacturing facility in Boulder, CO - is capable of producing a host of biologics. CEO Geoffrey Allan has testified before Congress on the need to authorize the FDA to move forward with the processes to bring generic biologics to U.S. approval.

"The patents on currently marketed biologics are expiring, and by 2010, the door will be open to a $12 billion market. Insmed has indicated they are currently developing several such proteins and expect to find a partner for the generic biologic market. Congress is opening the door to generic biologics and Insmed stands as one of only a few capable firms ready to participate."